Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citius Pharmaceuticals Inc (CTXR) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance

Citius Pharmaceuticals IncTrade
Vanguard Short Term Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

Citius Pharmaceuticals Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? Citius Pharmaceuticals Inc trades at $0.71 (market cap $20.01M), while Vanguard Short Term Corporate Bond ETF trades at $78.61. Which is the better fit depends on your goals.

CTXRVCSH
Market Cap
$20.01M
Sector
HealthFixed Income
52-Week High
$1.82$80.20
52-Week Low
$0.48$78.41
Enterprise Value
$16.23M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Citius Pharmaceuticals Inc

No Aura AI signal available yet.

Vanguard Short Term Corporate Bond ETF

VCSH trades at $78.615, up 0.16% with a bearish technical outlook as moving averages signal selling pressure while oscillators remain neutral. The ETF maintains a 4.77% yield with short 2.7-year duration, though recent analysis suggests limited upside due to tight credit spreads. Recent institutional activity shows mixed positioning with Apella Capital reducing holdings while Bessemer Group and Allspring increased stakes significantly.

The outlook remains cautious with downgrades to 'Hold' citing unattractive entry points, though the short duration provides downside protection. Key risks include credit spread widening and Fed policy uncertainty, while the primary opportunity lies in stable income generation for conservative investors seeking corporate bond exposure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR

About Vanguard Short Term Corporate Bond ETF

VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.

Read more on VCSH